SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015909
Filing Date
2022-03-30
Accepted
2022-03-29 18:31:11
Documents
67
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_hoththera.htm   iXBRL 10-K 1284498
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES f10k2021ex4-5_hoththera.htm EX-4.5 15367
3 SUBSIDIARIES OF THE REGISTRANT f10k2021ex21-1_hoththera.htm EX-21.1 1786
4 CONSENT OF WITHUMSMITH+BROWN, PC f10k2021ex23-1_hoththera.htm EX-23.1 1805
5 CERTIFICATION f10k2021ex31-1_hoththera.htm EX-31.1 11057
6 CERTIFICATION f10k2021ex31-2_hoththera.htm EX-31.2 11060
7 CERTIFICATION f10k2021ex32-1_hoththera.htm EX-32.1 4899
8 GRAPHIC image_001.jpg GRAPHIC 122286
  Complete submission text file 0001213900-22-015909.txt   5567590

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hoth-20211231.xsd EX-101.SCH 62768
10 XBRL CALCULATION FILE hoth-20211231_cal.xml EX-101.CAL 24547
11 XBRL DEFINITION FILE hoth-20211231_def.xml EX-101.DEF 247376
12 XBRL LABEL FILE hoth-20211231_lab.xml EX-101.LAB 503280
13 XBRL PRESENTATION FILE hoth-20211231_pre.xml EX-101.PRE 264461
61 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_hoththera_htm.xml XML 501936
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38803 | Film No.: 22782496
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences